日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Divergent FOXA1 mutations drive prostate tumorigenesis and therapy-resistant cellular plasticity.

FOXA1 基因突变导致前列腺肿瘤发生和细胞耐药性

Eyunni Sanjana, Mannan Rahul, Zhang Yuping, Young Eleanor, Zhang Qiuyang, Luo Jie, Pang Matthew, Mahapatra Somnath, Tien Jean Ching-Yi, George James M, Jaber Mustapha, Hakkani Hamzah, Carson Sandra E, Todd Abigail J, Hosseini Noshad, Gondal Mahnoor, Rebernick Ryan J, Cao Xuhong, Su Fengyun, Wang Rui, Mehra Rohit, Li Jing, Cieslik Marcin, Chinnaiyan Arul M, Parolia Abhijit

Author Correction: Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer

作者更正:靶向增强子依赖型前列腺癌中的SWI/SNF ATP酶

Xiao, Lanbo; Parolia, Abhijit; Qiao, Yuanyuan; Bawa, Pushpinder; Eyunni, Sanjana; Mannan, Rahul; Carson, Sandra E; Chang, Yu; Wang, Xiaoju; Zhang, Yuping; Vo, Josh N; Kregel, Steven; Simko, Stephanie A; Delekta, Andrew D; Jaber, Mustapha; Zheng, Heng; Apel, Ingrid J; McMurry, Lisa; Su, Fengyun; Wang, Rui; Zelenka-Wang, Sylvia; Sasmal, Sanjita; Khare, Leena; Mukherjee, Subhendu; Abbineni, Chandrasekhar; Aithal, Kiran; Bhakta, Mital S; Ghurye, Jay; Cao, Xuhong; Navone, Nora M; Nesvizhskii, Alexey I; Mehra, Rohit; Vaishampayan, Ulka; Blanchette, Marco; Wang, Yuzhuo; Samajdar, Susanta; Ramachandra, Murali; Chinnaiyan, Arul M

NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis

NSD2是AR/FOXA1新增强子复合物促进前列腺肿瘤发生所必需的亚基。

Parolia, Abhijit; Eyunni, Sanjana; Verma, Brijesh Kumar; Young, Eleanor; Liu, Lianchao; George, James; Aras, Shweta; Das, Chandan Kanta; Mannan, Rahul; Rasool, Reyaz Ur; Luo, Jie; Carson, Sandra E; Mitchell-Velasquez, Erick; Liu, Yihan; Xiao, Lanbo; Gajjala, Prathibha R; Jaber, Mustapha; Wang, Xiaoju; He, Tongchen; Qiao, Yuanyuan; Pang, Matthew; Zhang, Yuping; Alhusayan, Mohammed; Cao, Xuhong; Tavana, Omid; Hou, Caiyun; Wang, Zhen; Ding, Ke; Chinnaiyan, Arul M; Asangani, Irfan A